{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T04:11:52Z","timestamp":1743912712087,"version":"3.40.3"},"reference-count":32,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271112"],"award-info":[{"award-number":["82271112"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Natural Science Foundation Beijing, Tianjin, China","award":["J200007"],"award-info":[{"award-number":["J200007"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"accepted":{"date-parts":[[2024,8,3]]},"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>To construct and validate an optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) image model for predicting the occurrence of short-term vitreous haemorrhage (VH) in polypoidal choroidal vasculopathy (PCV) patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively collected clinical and imaging information from patients diagnosed with PCV at Peking Union Medical College Hospital, Beijing, China, between January 2015 and October 2022. Six different screening strategies, including univariate analysis, multivariate analysis, least absolute shrinkage and selection operator, stepwise logistic regression, random forest and clinical-data-only approach, were used to select variables and build models. The nomogram was constructed based on the model with the best area under the curve (AUC) and was evaluated using receiver operating characteristic curves, calibration curves, decision curve analysis and clinical impact curves.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 147 PCV patients were included and randomly divided into a training set (103 patients) and a validation set (44 patients), with an average follow-up time of 17.56\u00b114.99 months. The optimal model that achieved higher AUC in both training and validation sets incorporated seven significant variables identified through univariate analysis: male [OR=2.76, p=0.022], central macular thickness [OR=1.003, p=0.002], the presence of haemorrhagic pigment epithelial detachment (HPED) [OR=6.99, p&lt;0.001], the height of HPED [OR=1.002, p&lt;0.001], the area of HPED [OR=1.16, p&lt;0.001], the presence of multiple PEDs [OR=2.94, p=0.016] and the presence of subretinal haemorrhage [OR=3.11, p=0.011]. A predictive nomogram based on these variables yielded an AUC of 0.896 (95% CI 0.827 to 0.965) in the training set and 0.861 (95% CI 0.749 to 0.973) in the validation set, demonstrating good calibration and clinical usefulness.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The proposed OCT\/OCTA-based image nomogram, as a novel and non-invasive tool, achieved satisfactory prediction of VH secondary to PCV.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bjo-2024-325246","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T08:41:06Z","timestamp":1724488866000},"page":"391-400","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of optical coherence tomography (OCT) and OCT angiography prediction model for short-term vitreous haemorrhage secondary to polypoidal choroidal vasculopathy"],"prefix":"10.1136","volume":"109","author":[{"given":"Shiyu","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihui","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7231-5058","authenticated-orcid":false,"given":"Youxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,8,24]]},"reference":[{"key":"2025040422452009000_109.3.391.1","doi-asserted-by":"crossref","first-page":"e806","DOI":"10.1111\/aos.14683","article-title":"Pachychoroid spectrum disease","volume":"99","author":"Borooah","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"2025040422452009000_109.3.391.2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/APO.0000000000000573","article-title":"Polypoidal Choroidal Vasculopathy: updates on Risk Factors, Diagnosis, and Treatments","volume":"12","author":"Ruamviboonsuk","year":"2023","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"2025040422452009000_109.3.391.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.11.019"},{"key":"2025040422452009000_109.3.391.4","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11164766","article-title":"European Prevalence of Polypoidal Choroidal Vasculopathy: a Systematic Review, Meta-Analysis, and Forecasting Study","volume":"11","author":"van Dijk","year":"2022","journal-title":"J Clin Med"},{"key":"2025040422452009000_109.3.391.5","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/IAE.0000000000003666","article-title":"FIVE-YEAR INCIDENCE OF FELLOW EYE NEOVASCULAR INVOLVEMENT IN AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY IN AN ASIAN POPULATION","volume":"43","author":"Teo","year":"2023","journal-title":"Retina (Philadelphia, Pa)"},{"key":"2025040422452009000_109.3.391.6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/OPTH.S385827","article-title":"Polypoidal Choroidal Vasculopathy: an Update on Diagnosis and Treatment","volume":"17","author":"Sen","year":"2023","journal-title":"Clin Ophthalmol"},{"key":"2025040422452009000_109.3.391.7","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1097\/IAE.0b013e31822528c8","article-title":"VITREOUS HEMORRHAGE COMPLICATING INTRAVITREAL TISSUE PLASMINOGEN ACTIVATOR AND PNEUMATIC DISPLACEMENT OF SUBMACULAR HEMORRHAGE","volume":"31","author":"Wu","year":"2011","journal-title":"Retina (Philadelphia, Pa)"},{"key":"2025040422452009000_109.3.391.8","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/IAE.0000000000003098","article-title":"THE INCIDENCE, CHARACTERISTICS, MANAGEMENT, PROGNOSIS, AND CLASSIFICATION OF BREAKTHROUGH VITREOUS HEMORRHAGE SECONDARY TO POLYPOIDAL CHOROIDAL VASCULOPATHY","volume":"41","author":"Zhao","year":"2021","journal-title":"Retina (Philadelphia, Pa)"},{"key":"2025040422452009000_109.3.391.9","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.18240\/ijo.2019.12.07","article-title":"Long-term observation of vitrectomy without subretinal hemorrhage management for massive vitreous hemorrhage secondary to polypoidal choroidal vasculopathy","volume":"12","author":"Li","year":"2019","journal-title":"Int J Ophthalmol"},{"key":"2025040422452009000_109.3.391.10","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s10792-021-01744-x","article-title":"Surgical outcomes of vitrectomy for breakthrough vitreous hemorrhage in eyes with exudative age-related macular degeneration","volume":"41","author":"Iwase","year":"2021","journal-title":"Int Ophthalmol"},{"key":"2025040422452009000_109.3.391.11","first-page":"109","article-title":"Submacular Hemorrhage: visual Outcomes and Prognostic Factors","volume":"7","author":"Kunavisarut","year":"2019","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"2025040422452009000_109.3.391.12","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4103\/ijo.IJO_174_17","article-title":"Incidence, outcomes, and risk factors for hemorrhagic complications in eyes with polypoidal choroidal vasculopathy following photodynamic therapy in Indian subjects","volume":"65","author":"Rishi","year":"2017","journal-title":"Indian J Ophthalmol"},{"key":"2025040422452009000_109.3.391.13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/08820538.2018.1506483","article-title":"Prevalence and Risk Factors for Polypoidal Choroidal Vasculopathy in a General Japanese Population: the Hisayama Study","volume":"33","author":"Fujiwara","year":"2018","journal-title":"Semin Ophthalmol"},{"key":"2025040422452009000_109.3.391.14","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1089\/jop.2012.0148","article-title":"Incidence and risk factors for macular hemorrhage following intravitreal ranibizumab injection for neovascular age-related macular degeneration","volume":"29","author":"Moon","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"key":"2025040422452009000_109.3.391.15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jcjo.2016.02.012","article-title":"Hypertension as a risk factor for recurrent subretinal hemorrhage in polypoidal choroidal vasculopathy","volume":"51","author":"Chung","year":"2016","journal-title":"Can J Ophthalmol"},{"key":"2025040422452009000_109.3.391.16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28938-1","article-title":"Risk factors for breakthrough vitreous hemorrhage after intravitreal anti-VEGF injection in age-related macular degeneration with submacular hemorrhage","volume":"8","author":"Shin","year":"2018","journal-title":"Sci Rep"},{"key":"2025040422452009000_109.3.391.17","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181e2266d"},{"key":"2025040422452009000_109.3.391.18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ajo.2016.06.014","article-title":"Incidence Rate of Massive Submacular Hemorrhage and its Risk Factors in Polypoidal Choroidal Vasculopathy","volume":"169","author":"Cho","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"2025040422452009000_109.3.391.19","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/IAE.0000000000002384","article-title":"POSTTREATMENT POLYP REGRESSION AND RISK OF MASSIVE SUBMACULAR HEMORRHAGE IN EYES WITH POLYPOIDAL CHOROIDAL VASCULOPATHY","volume":"40","author":"Cho","year":"2020","journal-title":"Retina (Philadelphia, Pa)"},{"key":"2025040422452009000_109.3.391.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279778","article-title":"Clinical features and outcomes of breakthrough vitreous hemorrhage secondary to polypoidal choroidal vasculopathy","volume":"17","author":"Li","year":"2022","journal-title":"PLoS ONE"},{"key":"2025040422452009000_109.3.391.21","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-305674"},{"key":"2025040422452009000_109.3.391.22","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jamaophthalmol.2020.2443","article-title":"Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: the EVEREST II Randomized Clinical Trial","volume":"138","author":"Lim","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"2025040422452009000_109.3.391.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.08.006"},{"key":"2025040422452009000_109.3.391.24","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/jamia\/ocz228","article-title":"A tutorial on calibration measurements and calibration models for clinical prediction models","volume":"27","author":"Huang","year":"2020","journal-title":"J Am Med Inform Assoc"},{"key":"2025040422452009000_109.3.391.25","doi-asserted-by":"crossref","DOI":"10.1186\/s41512-019-0064-7","article-title":"A simple, step-by-step guide to interpreting decision curve analysis","volume":"3","author":"Vickers","year":"2019","journal-title":"Diagn Progn Res"},{"key":"2025040422452009000_109.3.391.26","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s40123-023-00783-0","article-title":"Systemic Risk Factors for Vitreous Hemorrhage Secondary to Polypoidal Choroidal Vasculopathy","volume":"12","author":"Liu","year":"2023","journal-title":"Ophthalmol Ther"},{"key":"2025040422452009000_109.3.391.27","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jcjo.2012.01.005","article-title":"Hemorrhagic complications after intravitreal ranibizumab injection for polypoidal choroidal vasculopathy","volume":"47","author":"Cho","year":"2012","journal-title":"Can J Ophthalmol"},{"key":"2025040422452009000_109.3.391.28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3341\/kjo.2020.0014","article-title":"Prognostic Factors and Long-term Surgical Outcomes for Exudative Age-related Macular Degeneration with Breakthrough Vitreous Hemorrhage","volume":"34","author":"Kim","year":"2020","journal-title":"Korean J Ophthalmol"},{"key":"2025040422452009000_109.3.391.29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.survophthal.2020.05.003","article-title":"Influence of pigment epithelial detachment on visual acuity in neovascular age-related macular degeneration","volume":"66","author":"Cheong","year":"2021","journal-title":"Surv Ophthalmol"},{"key":"2025040422452009000_109.3.391.30","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/IAE.0000000000001342","article-title":"QUANTITATIVE ANALYSIS OF PIGMENT EPITHELIAL DETACHMENT RESPONSE TO DIFFERENT ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS IN WET AGE-RELATED MACULAR DEGENERATION","volume":"37","author":"Balaskas","year":"2017","journal-title":"Retina (Philadelphia, Pa)"},{"key":"2025040422452009000_109.3.391.31","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3928\/23258160-20150610-07","article-title":"Quantification of Change in Pigment Epithelial Detachment Volume and Morphology After Transition to Intravitreal Aflibercept in Eyes With Recalcitrant Neovascular AMD: 18-Month Results","volume":"46","author":"Kanesa-Thasan","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"2025040422452009000_109.3.391.32","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2015151169"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjo-2024-325246","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T09:31:15Z","timestamp":1743845475000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjo-2024-325246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,24]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,2,24]]},"published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1136\/bjo-2024-325246"],"URL":"https:\/\/doi.org\/10.1136\/bjo-2024-325246","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"type":"print","value":"0007-1161"},{"type":"electronic","value":"1468-2079"}],"subject":[],"published":{"date-parts":[[2024,8,24]]}}}